Downmodulation of Tumor Suppressor P53 by T Cell Receptor Signaling is Critical for Antigen-specific CD4(+) T Cell Responses
Overview
Affiliations
Antigen specificity is critical in immune response and requires integration of antigen-specific signals with antigen-nonspecific signals such as those provided by cytokines. The mechanism integrating these pathways is incompletely understood. We report here that antigen-specific proliferative responses of CD4(+) T cells required downmodulation of tumor suppressor p53. In the absence of T cell receptor (TCR) signal, IL-2 induced sustained increase in p53 protein, which prevented proliferative responses despite strong signaling through the IL-2 receptor. In contrast, TCR signaling resulted in early termination of p53 protein expression by decreasing p53 mRNA as well as strong transcriptional induction of the p53-regulating protein Mdm2. Downmodulation of p53 in response to antigen stimulation was in fact critical for antigen-specific T cell proliferation, and preventing p53 degradation by inhibiting Mdm2 resulted in sustained p53 protein and prevented antigen-specific T cell proliferation. It is thus termination of p53 by TCR signaling that allows proliferative responses, enforcing antigen specificity.
Ursch L, Muschen J, Ritter J, Klermund J, Bernard B, Kolb S Cell Rep Med. 2024; 5(12):101846.
PMID: 39637860 PMC: 11722128. DOI: 10.1016/j.xcrm.2024.101846.
MDM2 inhibitors in cancer immunotherapy: Current status and perspective.
Zeng Q, Zeng S, Dai X, Ding Y, Huang C, Ruan R Genes Dis. 2024; 11(6):101279.
PMID: 39263534 PMC: 11388719. DOI: 10.1016/j.gendis.2024.101279.
ISG15/GRAIL1/CD3 axis influences survival of patients with esophageal adenocarcinoma.
McEwen D, Ray P, Nancarrow D, Wang Z, Kasturirangan S, Abdullah S JCI Insight. 2024; 9(13).
PMID: 38781019 PMC: 11383178. DOI: 10.1172/jci.insight.179315.
Understanding the complexity of p53 in a new era of tumor suppression.
Liu Y, Su Z, Tavana O, Gu W Cancer Cell. 2024; 42(6):946-967.
PMID: 38729160 PMC: 11190820. DOI: 10.1016/j.ccell.2024.04.009.
DNA framework signal amplification platform-based high-throughput systemic immune monitoring.
Chen Y, Chen X, Zhang B, Zhang Y, Li S, Liu Z Signal Transduct Target Ther. 2024; 9(1):28.
PMID: 38320992 PMC: 10847453. DOI: 10.1038/s41392-024-01736-0.